The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

Analysts at StockNews.com started coverage on shares of Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the ...